CompaniesEmerald Clinical Trials
Emerald Clinical Trials logo

Emerald Clinical Trials

active
Sydney, Australia
Founded 2005
Website
About

CRO providing a full range of trial management services.

Areas of Focus

Categories

Clinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchAustraliaClinical ResearchServices
Team (3)
Dr. Wong, could you tell us a bit about your time at The George Institute for Global Health?
MBBS, MRCP, PhD
Emerald Clinical Trials
team_member
How did you come to choose the medical field as a profession?
MD, PhD, Senior Medical Director
Emerald Clinical Trials
team_member
Scientific Leadership Team, Oncology
MBCHB, MD, FRACP, FRCP
Emerald Clinical Trials
team_member
Clinical Trials (19)
View all

Total Trials

19

As Lead Sponsor

5

As Collaborator

14

Total Enrollment

12,726

By Phase

PHASE2: 7EARLY_PHASE1: 1NA: 2PHASE3: 4PHASE1: 1PHASE4: 1

By Status

COMPLETED: 10RECRUITING: 3TERMINATED: 3ACTIVE_NOT_RECRUITING: 2UNKNOWN: 1
Clinical Trials Pipeline19 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT01330966
NCT01759303
NCT04049747
NCT04389827
NCT03969953
NCT04974008
Hover over trial bars to see details

Recent Trials

NCT07098663Collaborator
Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes
PHASE2Recruiting
68 participants
Started: Aug 12, 2025 · Completed: Apr 17, 2026
NCT06992141Collaborator
A Strep Throat Controlled Human Infection Trial in Healthy Adults
EARLY_PHASE1Recruiting
50 participants
Started: Jul 24, 2025 · Completed: Jun 30, 2027
NCT06689501Collaborator
12-Week Trial Investigating L-carnitine Tartrate, Dihydrocapsiate and Protein Yeast Hydrolysate on Energy Intake and Expenditure in Overweight Adults
NACompleted
44 participants
Started: Oct 30, 2024 · Completed: Jun 26, 2025
NCT04808531Collaborator
NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers
PHASE3Unknown
360 participants
Started: Nov 30, 2023 · Completed: Jun 30, 2024
NCT05200013Collaborator
BAT7104 in Patients With Advanced Solid Tumours
PHASE1Completed
14 participants
Started: Apr 29, 2022 · Completed: Jun 25, 2024
View all 19 trials →
Locations (1)
Headquarters
Sydney, Australia
Map

Loading map...